Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review

Background. Pleomorphic sarcoma is an aggressive soft tissue sarcoma. In patients with high-risk extremity sarcomas, the significant survival benefits conferred by an intense regimen of neoadjuvant chemoradiotherapy and surgery were reported. To our knowledge, this is the first report in the literat...

Full description

Saved in:
Bibliographic Details
Main Authors: Markus K. Schuler, Stephan Richter, Ivan Platzek, Bettina Beuthien-Baumann, Kathrin Wieczorek, Christine Hamann, Johannes Mohm, Gerhard Ehninger
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2013/320797
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850224613388189696
author Markus K. Schuler
Stephan Richter
Ivan Platzek
Bettina Beuthien-Baumann
Kathrin Wieczorek
Christine Hamann
Johannes Mohm
Gerhard Ehninger
author_facet Markus K. Schuler
Stephan Richter
Ivan Platzek
Bettina Beuthien-Baumann
Kathrin Wieczorek
Christine Hamann
Johannes Mohm
Gerhard Ehninger
author_sort Markus K. Schuler
collection DOAJ
description Background. Pleomorphic sarcoma is an aggressive soft tissue sarcoma. In patients with high-risk extremity sarcomas, the significant survival benefits conferred by an intense regimen of neoadjuvant chemoradiotherapy and surgery were reported. To our knowledge, this is the first report in the literature of the neoadjuvant use of trabectedin in a patient with high-grade pleomorphic sarcoma, ineligible for standard neoadjuvant combination therapy with an anthracycline-based regimen. Case Presentation. Here we present a 58-year-old White male with a large tumor in the left thigh, but with no signs of metastases. Owing to the history of severe heart attack, three cycles of neoadjuvant trabectedin were administrated to achieve surgically wide margins. After two cycles, an 18F-FDG-PET showed a large proportion of the central tumor area was without metabolic activity. According to RECIST and Choi criteria, the tumor was stable. After the third cycle of trabectedin, the patient underwent a complete resection, which revealed completely necrotic high-grade pleomorphic sarcoma (stage pT2b), with only a small vital area. Conclusion. The present paper on a promising treatment with neoadjuvant trabectedin of patients with high-grade pleomorphic sarcoma might suggest that such treatment approach may provide a greater chance of cure and survival of such patients.
format Article
id doaj-art-4ee7db77176e4e059c199167fc4b6cb5
institution OA Journals
issn 2090-6706
2090-6714
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-4ee7db77176e4e059c199167fc4b6cb52025-08-20T02:05:35ZengWileyCase Reports in Oncological Medicine2090-67062090-67142013-01-01201310.1155/2013/320797320797Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature ReviewMarkus K. Schuler0Stephan Richter1Ivan Platzek2Bettina Beuthien-Baumann3Kathrin Wieczorek4Christine Hamann5Johannes Mohm6Gerhard Ehninger7Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyDepartment of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyDepartment of Radiology, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyDepartment of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyDepartment of Pathology, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyDepartment of Orthopaedics, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyHämatologisch-Onkologische Praxis, Dresden, GermanyDepartment of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, GermanyBackground. Pleomorphic sarcoma is an aggressive soft tissue sarcoma. In patients with high-risk extremity sarcomas, the significant survival benefits conferred by an intense regimen of neoadjuvant chemoradiotherapy and surgery were reported. To our knowledge, this is the first report in the literature of the neoadjuvant use of trabectedin in a patient with high-grade pleomorphic sarcoma, ineligible for standard neoadjuvant combination therapy with an anthracycline-based regimen. Case Presentation. Here we present a 58-year-old White male with a large tumor in the left thigh, but with no signs of metastases. Owing to the history of severe heart attack, three cycles of neoadjuvant trabectedin were administrated to achieve surgically wide margins. After two cycles, an 18F-FDG-PET showed a large proportion of the central tumor area was without metabolic activity. According to RECIST and Choi criteria, the tumor was stable. After the third cycle of trabectedin, the patient underwent a complete resection, which revealed completely necrotic high-grade pleomorphic sarcoma (stage pT2b), with only a small vital area. Conclusion. The present paper on a promising treatment with neoadjuvant trabectedin of patients with high-grade pleomorphic sarcoma might suggest that such treatment approach may provide a greater chance of cure and survival of such patients.http://dx.doi.org/10.1155/2013/320797
spellingShingle Markus K. Schuler
Stephan Richter
Ivan Platzek
Bettina Beuthien-Baumann
Kathrin Wieczorek
Christine Hamann
Johannes Mohm
Gerhard Ehninger
Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
Case Reports in Oncological Medicine
title Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
title_full Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
title_fullStr Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
title_full_unstemmed Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
title_short Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
title_sort trabectedin in the neoadjuvant treatment of high grade pleomorphic sarcoma report of a rare case and literature review
url http://dx.doi.org/10.1155/2013/320797
work_keys_str_mv AT markuskschuler trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT stephanrichter trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT ivanplatzek trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT bettinabeuthienbaumann trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT kathrinwieczorek trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT christinehamann trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT johannesmohm trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview
AT gerhardehninger trabectedinintheneoadjuvanttreatmentofhighgradepleomorphicsarcomareportofararecaseandliteraturereview